Cargando…
Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy
Pancreatic cancer is one of the deadliest cancers owing to its late diagnosis and of the strong resistance to available treatments. Despite a better understanding of the disease in the last two decades, no significant improvement in patient care has been made. Senescent cells are characterized by a...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899302/ https://www.ncbi.nlm.nih.gov/pubmed/36739330 http://dx.doi.org/10.1186/s43556-023-00116-4 |